Anchiano Therapeutics Competitors and Similar CompaniesClear all
Anchiano Therapeutics's competitors and similar companies include Kymab and enVVeno.
 Anchiano Therapeutics Anchiano Therapeutics is a clinical-stage biotechnology company that develops gene therapies to treat early-stage bladder cancer. |  Kymab Kymab is a biopharmaceutical company which discovers and develops human monoclonal antibody therapeutics. |  enVVeno Envveno Medical (formerly known as Hancock Jaffe) is a company developing biologic-based solutions that are designed to be life enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease (ESRD). | |
Founding Date | Founding Date 2004 | Founding Date 2009 | Founding Date 1987 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations Cambridge, US HQ | Locations Cambridge, GB HQ | Locations Irvine, US HQ |
Employees | Employees 1912% increase | Employees 407% decrease | Employees 1525% increase |
Valuation ($) | Valuation ($) 34.9 m | Valuation ($) N/A | Valuation ($) 88.4 m |
Financial | |||
Net income | Net income $9.8m (FY, 2017) | Net income N/A | Net income ($19.5m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 29m | Total funding raised $ 220.4m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Kymab
HQ
Cambridge, GB
Employees
40↓ 7% decrease
Kymab is a biopharmaceutical company which discovers and develops human monoclonal antibody therapeutics.
View companyenVVeno
HQ
Irvine, US
Employees
15↑ 25% increase
Envveno Medical (formerly known as Hancock Jaffe) is a company developing biologic-based solutions that are designed to be life enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease (ESRD).
View company